Hypoxia-activatable nano-prodrug for fluorescently tracking drug release in mice
- 18 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Science in China Series B Chemistry
- Vol. 64 (3), 499-508
- https://doi.org/10.1007/s11426-020-9880-7
Abstract
No abstract availableThis publication has 46 references indexed in Scilit:
- Engineering a Prostate-Specific Membrane Antigen–Activated Tumor Endothelial Cell Prodrug for Cancer TherapyScience Translational Medicine, 2012
- Transferrin-Conjugated Micelles: Enhanced Accumulation and Antitumor Effect for Transferrin-Receptor-Overexpressing Cancer ModelsMolecular Pharmaceutics, 2012
- Hypoxia Predicts Aggressive Growth and Spontaneous Metastasis Formation from Orthotopically Grown Primary Xenografts of Human Pancreatic CancerCancer Research, 2011
- ABC Efflux Pump-Based Resistance to Chemotherapy DrugsChemical Reviews, 2009
- Hypoxia and Aggressive Tumor Phenotype: Implications for Therapy and PrognosisThe Oncologist, 2008
- Hypoxia: A key regulator of angiogenesis in cancerCancer and Metastasis Reviews, 2007
- Exploiting tumour hypoxia in cancer treatmentNature Reviews Cancer, 2004
- Hypoxia promotes invasive growth by transcriptional activation of the met protooncogeneCancer Cell, 2003
- Imaging hypoxia in tumorsSeminars in Nuclear Medicine, 2001
- Inter-strand crosslinking of DNA by nitrogen mustardJournal of Molecular Biology, 1966